The website of Pathology In Practice Magazine

Revolutionising pancreatic elastase testing

Faecal pancreatic elastase testing can now be automated, providing flexible and random-access application on most clinical chemistry platforms. The new fPELA turbo from BÜHLMANN is ideal for identification and monitoring of pancreatic insufficiency.

There is the added advantage that it utilises the same CALEX extraction device as the fCAL turbo assay, so it is possible to run both tests from a single extract.

The fPELA technology is a milestone in automation of pancreatic elastase quantification. It reduces the hands-on time dramatically and allows reporting of pancreatic elastase results from human stool samples within the shortest time. Time to first result is just 10 minutes, with further results following every few seconds thereafter, making it one of the fastest faecal elastase assays available.

Tel: 0800 38 77 32

Email: [email protected] 

Web: www.alphalabs.co.uk/fpela 

Upcoming Events

Every Minute Counts: a SHOT, BBTS and NBTC joint webinar

Online
3 December 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

Every Minute Counts: a SHOT, BBTS and NBTC joint webinar

Online
3 December 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2021 Step Communications Ltd. Registered in England. Registration Number 3893025